Shen Q, Zou S, Sheng B, Zhao M, Sun LZ, & Zhu X. (2019). Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas. Dove Medical Press.
Chicago Style (17th ed.) CitationShen Q, Zou S, Sheng B, Zhao M, Sun LZ, and Zhu X. Mifepristone Inhibits IGF-1 Signaling Pathway in the Treatment of Uterine Leiomyomas. Dove Medical Press, 2019.
MLA (9th ed.) CitationShen Q, et al. Mifepristone Inhibits IGF-1 Signaling Pathway in the Treatment of Uterine Leiomyomas. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.